Oryzon to present at upcoming international conferences
MADRID, SPAIN and CAMBRIDGE MA.
• European Biotech Investor Day in NYC, New York, USA
• The Alzheimer's Association International Conference AAIC- 2018 – Chicago, USA
Oryzon Genomics (ISIN Code: ES0167733015, ORY), a public clinical-stage biopharmaceutical company leveraging epigenetics to develop therapies in diseases with strong unmet medical need, has announced today that Executive Directors of the company will present at several international reputed conferences in July.